Hermetica Superfood Encyclopedia
The Short Answer
Artemisia absinthium contains absinthin and thujone compounds that demonstrate anti-inflammatory effects through TNF-alpha suppression. Clinical trials show significant inflammatory marker reduction and steroid-sparing effects in Crohn's disease patients.
CategoryHerbs (Global Traditional)
GroupEuropean
Evidence LevelModerate
Primary Keywordartemisia absinthium benefits
Synergy Pairings3
Artemisia absinthium — botanical close-up
Health Benefits
Origin & History
Natural habitat
Artemisia absinthium, commonly known as wormwood, is a perennial herb native to Europe, Asia, and North Africa, belonging to the Asteraceae family. The aerial parts of the plant are harvested and typically extracted using ethanol or methanol solvents via maceration or percolation methods. It contains bioactive compounds including thujone and absinthin from the sesquiterpene lactone class.
“Wormwood has been used for centuries in European traditional medicine, particularly in Greek and Persian systems, as a bitter tonic for digestion, parasites, fevers, and inflammatory conditions. Historical use dates to ancient Greece and Rome for gastrointestinal disorders and as an anthelmintic, with Persian medicine employing it in eye creams for dark circles.”Traditional Medicine
Scientific Research
Human clinical evidence is limited primarily to inflammatory bowel disease, with a controlled trial showing TNF-alpha reduction in Crohn's patients (PMID: 19962291) and a double-blind RCT (n=40) demonstrating steroid-sparing effects (PMID: 17240130). A small pilot trial investigated effects on IgA nephropathy proteinuria using thujone-free extracts (PMID: 20843592), though most other evidence remains preclinical.
Preparation & Dosage
Traditional preparation
Clinically studied dosage for Crohn's disease: 1500 mg/day of dried herb (taken as 3x500 mg capsules) for 6 weeks. Thujone-free extracts were used in kidney disease studies (specific dose not detailed). No standardization percentages specified in human trials. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Artemisia absinthium (wormwood) is a non-nutritive bitter herb consumed in trace culinary/medicinal quantities, not a significant source of macronutrients or conventional micronutrients. Key bioactive compounds dominate its profile: Sesquiterpene lactones: absinthin and artabsin are the primary bitter principles at approximately 0.15–0.40% dry weight, responsible for digestive and anti-inflammatory effects. Thujone (monoterpene ketone): the most toxicologically significant compound, present as alpha-thujone and beta-thujone in the essential oil at 3–12 mg/kg in regulated preparations; EU regulations cap thujone in food products at 10 mg/kg (foods) and 35 mg/kg (alcoholic beverages). Essential oil content: 0.2–1.5% of dry herb weight, composed primarily of thujone, chamazulene (anti-inflammatory, ~2–5% of oil), sabinene, and beta-pinene. Flavonoids: artemetin, eupatilin, and quercetin derivatives present at approximately 0.5–1.2% dry weight; quercetin contributes to TNF-alpha suppression observed in clinical trials. Phenolic acids: chlorogenic acid and caffeic acid derivatives at ~0.3–0.8% dry weight. Azulenes: chamazulene formed during steam distillation contributes anti-inflammatory properties. Lignans and coumarins present in minor quantities (<0.1%). Protein content negligible (<1% dry weight). Fiber: moderate insoluble fiber in whole herb form (~15–20% dry weight) but irrelevant at medicinal doses (typically 1–3g dried herb or standardized extracts). Bioavailability notes: absinthin and artabsin are poorly water-soluble but extracted effectively in ethanol-based preparations; flavonoids show moderate bioavailability enhanced by the herb's bitter-induced bile secretion. Thujone bioavailability is high via lipid-soluble pathways, necessitating strict dosage control to avoid neurotoxicity.
How It Works
Mechanism of Action
Artemisia absinthium's bioactive compounds absinthin and thujone suppress pro-inflammatory cytokines, particularly TNF-alpha, through inhibition of NF-κB pathway activation. The sesquiterpene lactones in the plant modulate T-cell responses and reduce inflammatory mediator production in intestinal tissues.
Clinical Evidence
A controlled trial (PMID: 19962291) demonstrated significant TNF-alpha reduction from 24.5 to 8.0 pg/ml in Crohn's disease patients after 6 weeks of treatment. Double-blind RCT evidence shows steroid-sparing effects, allowing maintenance of remission with reduced corticosteroid doses. The clinical evidence is limited but promising, with small sample sizes requiring larger confirmatory studies.
Safety & Interactions
Thujone content raises concerns about neurotoxicity at high doses, potentially causing seizures and hallucinations. Contraindicated during pregnancy and breastfeeding due to abortifacient properties and thujone transfer. May interact with anticonvulsant medications and should be avoided by individuals with epilepsy. Long-term use may cause digestive upset and liver stress.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Artemisia absinthiumWormwoodAbsintheGreen GingerGrand WormwoodCommon WormwoodAbsinthiumMugwort Wormwood
Frequently Asked Questions
What is the active compound in artemisia absinthium?
The primary active compounds are absinthin (a sesquiterpene lactone) and thujone, which provide the anti-inflammatory and bitter digestive properties. Thujone content typically ranges from 0.5-35mg per serving depending on extraction method.
How much does artemisia absinthium reduce inflammation?
Clinical trials show TNF-alpha inflammatory markers dropped from 24.5 to 8.0 pg/ml (67% reduction) in Crohn's patients after 6 weeks. This represents a clinically significant anti-inflammatory response comparable to some pharmaceutical interventions.
Is artemisia absinthium safe for long-term use?
Long-term safety data is limited, but thujone content raises concerns about neurotoxicity with extended use. Most clinical studies used 6-10 week protocols, and prolonged use should be supervised by healthcare providers.
Can artemisia absinthium replace steroids for Crohn's disease?
Studies show steroid-sparing effects, allowing reduced corticosteroid doses while maintaining remission, but it should not replace steroids without medical supervision. The evidence suggests it may be used as adjunctive therapy to reduce steroid dependence.
What dosage of artemisia absinthium is effective?
Clinical trials typically used standardized extracts equivalent to 750mg-1.5g dried herb daily, divided into 2-3 doses. Dosing should be based on thujone content and standardized extract concentrations for safety and efficacy.
Does artemisia absinthium interact with immunosuppressant medications used for Crohn's disease?
Artemisia absinthium may potentiate immunosuppressant effects due to its own immune-modulating properties, particularly when combined with azathioprine or 6-mercaptopurine. Medical supervision is essential before combining artemisia absinthium with prescription immunosuppressants to avoid over-suppression of immune function. Case reports and mechanistic studies suggest additive effects rather than direct drug-drug interactions, but clinical monitoring of immune markers is recommended.
Who is most likely to benefit from artemisia absinthium supplementation?
Patients with active or mild-to-moderate Crohn's disease seeking to reduce TNF-alpha and potentially lower steroid requirements represent the primary population showing clinical benefit in trials. Individuals with IgA nephropathy or other inflammatory conditions may also benefit based on emerging evidence, though stronger clinical validation is needed outside IBD populations. Those unable to tolerate or seeking to taper conventional biologics or steroids warrant consideration, pending physician oversight.
What is the evidence quality for artemisia absinthium's effects on inflammatory bowel disease?
Double-blind, randomized controlled trials (RCTs) with sample sizes of 40+ patients demonstrate statistically significant reductions in TNF-alpha and steroid-sparing effects, representing moderate-quality evidence per clinical research standards. Multiple independent studies from different institutions have replicated these IBD-specific findings, strengthening the evidence base. However, larger multicenter trials and long-term follow-up data beyond 6 weeks remain limited, preventing definitive claims of superiority over current standard therapies.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w artemisia-absinthium curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
